Clinical Trial Update: Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating continuous infusion of fludarabine and cytarabine with G-CSF priming for elderly patients with resistant acute myeloid leuk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Filgrastim (filgrastim)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Cooperative Study Group A for Hematology | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: UNKNOWN